Millie
your market intelligence analyst
Search Results
Edit Save
1,217 results
Labiotech.eu (EU) 09/16/2019 04:00
An initial public offering (IPO) can come with many benefits, such as raising capital, increasing public awareness, and growing a company’s market share. However, initiating an IPO can be quite challenging, especially for companies who are new to the process. For this reason, the pan-European stock exchange Euronext started an annual pre-IPO program, which is […]. .
Labiotech.eu (EU) 09/13/2019 12:19
The Icelandic genomics company deCODE genetics has joined the UK’s Wellcome Sanger Institute in sequencing 450,000 genomes as part of a massive €224M (£200M) project organized by the UK Biobank initiative. The UK Biobank’s €224M grant includes €56M (£50M) from the UK government, €56M from the UK’s Wellcome Trust charity, and €112M (£100M) from big […]. .
Labiotech.eu (EU) 09/12/2019 11:37
This is an extraordinary year for BIO-Europe, because it’s celebrating its 25th anniversary. Congratulations! 🎉 As Europe’s biggest biotech event, Bio-Europe attracted 4,300+ attendees from 2,300+ companies in 2018. What’s even more amazing is that they helped coordinate over 26,000 meetings where biotech professionals gathered around to partner with each other and foster innovation. Labiotech […]. .
Labiotech.eu (EU) 09/12/2019 09:29
The French company Inotrem has raised €39M to fund an immunotherapy for septic shock, an often deadly condition caused by infections in the bloodstream. Led by the Hong Kong investor Morningside Ventures, the Series B round will finance a phase IIb trial of Inotrem’s lead candidate drug nangibotide, expected to start in November this year. […]. .
Labiotech.eu (EU) 09/12/2019 04:00
Although it’s becoming increasingly popular in life science marketing, branded content is still in its infancy. This does not mean it isn’t worth investing. Quite the contrary: because it is fairly new, it is all the more exciting and can reach promising audiences within the life sciences industry. While other industries have long since jumped […]. .
Labiotech.eu (EU) 09/11/2019 13:00
The Dutch pharmaceutical company Pharvaris has raked in €60M in a Series B round to fund the clinical development of the first oral treatment for hereditary angioedema, a condition that causes swelling in the limbs and airways. The Series B round will fuel the clinical progress of Pharvaris’ oral small molecule treatment for hereditary angioedema, […]. .
Labiotech.eu (EU) 09/11/2019 10:14
The Hôpitaux Universitaires Genève in Switzerland will be the first European university hospital to implement IBM’s artificial intelligence to help doctors select treatments for complex cancer cases. “Artificial intelligence could empower our clinicians to increase the speed of diagnosing their patients,” said Rodolphe Meyer, who is responsible for the IT department of the Hôpitaux Universitaires […]. .
Labiotech.eu (EU) 09/11/2019 08:37
The German pharmaceutical company Grünenthal has licensed a donor cell therapy for chronic low back pain from the Australian biotech Mesoblast in a deal that could be worth over €900M. Under the terms of the deal, Grünenthal will gain exclusive rights to commercialize Mesoblast’s cell therapy for chronic low back pain in Europe and Latin […]. .
Labiotech.eu (EU) 09/11/2019 04:22
Hello biotechies, Job hunt frustration? Don’t worry, we’re here to help. Check out the exclusive offer from Colorifix or become a Food Scientist at NOQUO FOODS. Just starting out? Check out the internship at Helmholtz Centre for Environmental Research! Exclusive Offers Materials Specialist at Colorifix. Norwich, United Kingdom. Click here Computational Biologist at Colorifix. Norwich, United […]. .
Labiotech.eu (EU) 09/11/2019 04:00
In recent years, Europe has seen a tremendous shift regarding the legalization, cultivation, and trade of medical cannabis. This arguably started when Germany legalized cannabis for medical use in 2017, which seems to have had a persuasive effect on other EU member states. Since then, a lot has happened. In Europe, Portugal, Denmark, Poland, and […]. .
Labiotech.eu (EU) 09/10/2019 07:57
A blood test for anti-cancer antibodies, developed by the UK diagnostics company Oncimmune, detected more early cases of lung cancer than standard clinical monitoring procedures in a trial with more than 12,000 patients. Oncimmune’s trial recruited 12,209 patients with a high risk of developing lung cancer through smoking and family history, and monitored them for […]. .
Labiotech.eu (EU) 09/10/2019 06:30
CAR-T therapy has been hailed as a cure for cancer, but what really is this ‘miraculous technology’ and what can we actually expect from it? The field of immuno-oncology is booming with billions of euros in investment. The ability to rewire our own immune system to fight cancer has certainly created huge expectations. After the […]. .
Labiotech.eu (EU) 09/09/2019 12:17
September has launched with lots of fascinating biotech news! Try as we might, we can’t cover everything that is out there. So relax, have a warm drink, and check out what has happened over the last week. Collaborations The German biotechs Velabs Therapeutics and alytas therapeutics have joined forces to develop immunotherapies that could treat […]. .
Labiotech.eu (EU) 09/09/2019 04:00
The misuse of prescription drugs for non-medical purposes has become an increasing problem worldwide. Together with Evotec, we have taken a look at how biopharma companies can prevent prescription drug abuse by taking drugs through strict assessment processes. Check out the new infographic below! You can also download a free version here! Are you struggling […]. .
Labiotech.eu (EU) 09/06/2019 06:26
In the university town of Umeå, Sweden, the biotech company Omnio is developing treatments for tooth loss in conditions such as periodontitis. Mission: To promote wound healing by enhancing the action of plasminogen, a protein in the blood that is important in the healing process. Enhancing the action of this molecule could allow the company […]. .

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications